SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Djureinovic Dijana)
 

Search: WFRF:(Djureinovic Dijana) > Detection of autoan...

Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer

Djureinovic, Dijana (author)
Uppsala universitet,Klinisk och experimentell patologi,Patrick Micke
Dodig-Crnkovic, Tea (author)
KTH,Affinitets-proteomik,Science for Life Laboratory, SciLifeLab,Affinity Proteomics, SciLifeLab, School of Biotechnology, KTH - Royal Institute of Technology, Solna, Sweden
Hellström, Cecilia (author)
KTH,Affinitets-proteomik,Science for Life Laboratory, SciLifeLab,Affinity Proteomics, SciLifeLab, School of Biotechnology, KTH - Royal Institute of Technology, Solna, Sweden
show more...
Holgersson, Georg (author)
Uppsala universitet,Experimentell och klinisk onkologi
Bergqvist, Michael (author)
Department of Oncology, Gavle Hospital, Gavle, Sweden.
Mattsson, Johanna Sofia Margareta, 1985- (author)
Uppsala universitet,Klinisk och experimentell patologi,Patrick Micke
Ponten, Fredrik (author)
Uppsala universitet,Klinisk och experimentell patologi,Fredrik Pontén
Ståhle, Elisabeth (author)
Uppsala universitet,Thoraxkirurgi,Uppsala kliniska forskningscentrum (UCR)
Schwenk, Jochen M. (author)
KTH,Science for Life Laboratory, SciLifeLab,Affinitets-proteomik,Affinity Proteomics, SciLifeLab, School of Biotechnology, KTH - Royal Institute of Technology, Solna, Sweden
Micke, Patrick (author)
Uppsala universitet,Klinisk och experimentell patologi,Patrick Micke
show less...
 (creator_code:org_t)
Elsevier BV, 2018
2018
English.
In: Lung Cancer. - : Elsevier BV. - 0169-5002 .- 1872-8332. ; 125, s. 157-163
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Cancer testis antigens (CTAs) are defined as proteins that are specifically expressed in testis or placenta and their expression is frequently activated in cancer. Due to their ability to induce an immune response, CTAs may serve as suitable targets for immunotherapy. The aim of this study was to evaluate if there is reactivity against CTAs in the plasma of non-small cell lung cancer (NSCLC) patients through the detection of circulating antibodies. To comprehensively analyse auto-antibodies against CTAs the multiplexing capacities of suspension bead array technology was used. Bead arrays were created with 120 protein fragments, representing 112 CTAs. Reactivity profiles were measured in plasma samples from 133 NSCLC patients and 57 cases with benign lung diseases. Altogether reactivity against 69 antigens, representing 81 CTAs, was demonstrated in at least one of the analysed samples. Twenty-nine of the antigens (45 CTAs) demonstrated exclusive reactivity in NSCLC samples. Reactivity against CT47A genes, PAGE3, VCX, MAGEB1, LIN28B and C12orf54 were only found in NSCLC patients at a frequency of 1%-4%. The presence of autoantibodies towards these six antigens was confirmed in an independent group of 34 NSCLC patients.In conclusion, we identified autoantibodies against CTAs in the plasma of lung cancer patients. The reactivity pattern of autoantibodies was higher in cancer patients compared to the benign group, stable over time, but low in frequency of occurrence. The findings suggest that some CTAs are immunogenic and that these properties can be utilized as immune targets.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Klinisk laboratoriemedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Clinical Laboratory Medicine (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinsk bioteknologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Medical Biotechnology (hsv//eng)

Keyword

Lung cancer
adenocarcinoma
squamous cell cancer
cancer immunity
tumor markers
MAGE
PAGE
Patologi
Pathology

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view